F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

R. Cavallo Clinical Microbiology and Infection

Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013 J. Verschueren, L. Cnops,

L. Boyanova Clinical Microbiology and Infection

High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China X.-S. Chen, Y.-P. Yin, W.-H. Wei, H.-C. Wang,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals G. Ippolito Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Virological tools to diagnose and monitor hepatitis C virus infection

The microarray technology: facts and controversies

Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16α-bromoepiandrosterone (HE2000) C. Reading,

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

An eye-catching acanthocephalan

Drug-resistant human immunodefiency virus

Peptide insertions in reverse transcriptase pol gene of human immunodeficiency virus type 1 as a rare cause of persistent antiretroviral therapeutic failure

Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.

Vector control: a cornerstone in the malaria elimination campaign

Training for the infectious diseases speciality in Norway

Detection of human metapneumovirus and respiratory syncytial virus by duplex real-time RT-PCR assay in comparison with direct fluorescent assay P. Jokela,

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman Clinical.

V Duque, ÁA. Holguín, M. Silvestre, J. GonzÁAlez-Lahoz, V. Soriano

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Long-term mortality following bloodstream infection

New developments in laboratory monitoring of HIV-1 infection

Update on antifungal resistance in Aspergillus and Candida

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection E. Knops, E. Heger Clinical Microbiology.

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

A.P. Underwood, J. Green Clinical Microbiology and Infection

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

F.J. Pastor, J. Guarro Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Diversity and evolution of methods and practices for the molecular diagnosis of congenital toxoplasmosis in France: a 4-year survey Y. Sterkers, E. Varlet-Marie,

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study R. Goering, C.-E. Nord, R.

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

New patterns of HIV-1 resistance during HAART

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Vincent Calvez, Marc Grandadam Clinical Microbiology and Infection

Presentation transcript:

The use of human immunodeficiency virus resistance tests in clinical practice F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno Clinical Microbiology and Infection Volume 16, Issue 10, Pages 1511-1517 (October 2010) DOI: 10.1111/j.1469-0691.2010.03353.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Histograms representing the number of genotypic resistance tests (GRTs) performed in our virology laboratory in Rome in the last 10 years. (a) Number of pol (protease (PR)/reverse transcriptase (RT)) GRTs performed over the years. (b) Number of GRTs of PR/RT, GP41, integrase and V3-Gp120 performed over the years. The numbers given at the top of the ‘overall’ bar indicate the total number of GRTs per year. Clinical Microbiology and Infection 2010 16, 1511-1517DOI: (10.1111/j.1469-0691.2010.03353.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Number of genotypic resistance tests (GRTs) performed at first treatment failure in relation to viral load and year of treatment start. Clinical Microbiology and Infection 2010 16, 1511-1517DOI: (10.1111/j.1469-0691.2010.03353.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions